| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT05869903 A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With… |
Primary endpoint(s) modified |
| 2026-08-13 | NCT04527380 A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis… |
date change Completion pushed: 2028-04 -> 2029-01 |
| 2026-08-12 | NCT04232553 A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's… |
date change Completion pushed: 2027-04 -> 2028-03 |
| 2026-08-08 | NCT03706365 A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in… |
date change Completion pushed: 2026-06 -> 2026-12 |
| 2026-08-08 | NCT07157774 Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated… |
Trial sites expanded: 772 -> 785 locations |
| 2026-08-08 | NCT04280081 A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including… |
date change Completion pushed: 2027-11 -> 2028-11 |
| 2026-08-08 | NCT06890598 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With… |
Trial sites expanded: 366 -> 370 locations |
| 2026-08-07 | NCT07353931 Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee… |
Trial sites reduced: 161 -> 152 locations |
| 2026-08-07 | NCT07369011 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and… |
Trial sites reduced: 129 -> 115 locations |
| 2026-08-07 | NCT07392190 A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are… |
Trial sites expanded: 173 -> 188 locations |
| 2026-08-07 | NCT07174336 A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in… |
Trial sites expanded: 346 -> 353 locations |
| 2026-08-07 | NCT07287098 A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen… |
Trial sites expanded: 78 -> 86 locations |
| 2026-08-07 | NCT07223593 Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease |
Trial sites expanded: 154 -> 157 locations |
| 2026-08-06 | NCT03952559 A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis |
Trial completed |
| 2026-08-01 | NCT06993792 A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight… |
Enrollment increased: 1200 -> 1400 participants |
| 2026-07-31 | NCT05882045 A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease |
Trial completed |
| 2026-07-31 | NCT07533019 A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo |
Enrollment increased: 60 -> 66 participants |
| 2026-07-31 | NCT07174336 A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in… |
Enrollment reduced: 920 -> 800 participants |
| 2026-07-31 | NCT07174336 A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in… |
Trial sites expanded: 338 -> 346 locations |
| 2026-07-31 | NCT05929079 A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have… |
Trial completed |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-14 | NCT07765498 A Study of LY4355756 in Healthy Participants | Phase 1 | Not Yet Recruiting |
| 2026-08-14 | NCT07765511 A Study of Macupatide (LY3532226) in Participants With Obesity or Overweight Without Type… | Phase 1 | Not Yet Recruiting |
| 2026-08-12 | NCT07759245 A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic… | Phase 2 | Not Yet Recruiting |
| 2026-07-31 | NCT07738614 A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06876649 | A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib | Chronic Lymphocytic Leukemia | Recruiting |
| NCT06876662 | A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT07438444 | A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2… | Diabetes Mellitus, Type 2 | Recruiting |
| NCT06857942 | A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation… | Psoriasis | Recruiting |
| NCT06864026 | A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in… | Psoriatic Arthritis | Recruiting |
| NCT07247084 | A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants… | Obesity | Recruiting |
| NCT07218341 | A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT05433584 | A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants… | Type 2 Diabetes | Active, Not Recruiting |
| NCT07006792 | A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic… | Atopic Dermatitis | Active, Not Recruiting |
| NCT07612267 | A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving… | Lactation | Not Yet Recruiting |
| Phase 3 | |||
| NCT07142954 | Epidemiology and Biomarker Study in Alzheimer's Disease | Alzheimer Disease | Recruiting |
| NCT07602582 | A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM… | Alzheimer Disease | Recruiting |
| NCT07218380 | A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract | Carcinoma, Transitional Cell | Recruiting |
| NCT05723198 | A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age… | Areata Alopecia | Recruiting |
| NCT06119581 | A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without… | Carcinoma, Non-Small-Cell Lung | Recruiting |
| NCT06672549 | A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) | Obesity | Recruiting |
| NCT06672939 | A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or… | Obesity | Recruiting |
| NCT06338995 | A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal… | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | Recruiting |
| NCT06937086 | Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With… | Ulcerative Colitis | Recruiting |
| NCT06937099 | Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to… | Crohn's Disease | Recruiting |
| NCT07153471 | A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and… | Osteoarthritis | Recruiting |
| NCT07165028 | A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated… | Metabolic Dysfunction-Associated Steatotic Liver Disease | Recruiting |
| NCT07174336 | A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in… | Breast Neoplasms | Recruiting |
| NCT07202884 | A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have… | Urinary Incontinence,Stress | Recruiting |
| NCT07213804 | A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With… | Ovarian Neoplasms | Recruiting |